Related Experiment Video
Updated: Jan 16, 2026

05:23
Investigating Migraine-Like Behavior Using Light Aversion in Mice
Published on: August 11, 2021
4.4K
CREB-KIF1A-CGRP-positive feedback loop drives central sensitization in chronic migraine
Wei Jiang1, Peng Yu2, Yan-Min Shi3
1Department of Neurology and Neuroscience Center, The First Hospital of Jilin University, 1 Xinmin Street, Changchun, 130021, China.
The Journal of Headache and Pain
|October 1, 2025
Summary
Researchers uncovered a CREB-KIF1A-CGRP positive feedback loop driving chronic migraine. Targeting this pathway, involving CREB regulation of KIF1A and CGRP, offers potential new treatments for migraine.
Area of Science:
- Neuroscience
- Molecular Biology
- Pharmacology
Background:
- Chronic migraine (CM) is a complex neurological disorder with unclear upstream regulation of calcitonin gene-related peptide (CGRP).
- Kinesin family member 1A (KIF1A), crucial for axonal transport, is regulated by cAMP response element-binding protein (CREB).
Purpose of the Study:
- To investigate the role of the CREB-KIF1A-CGRP signaling axis in migraine pathogenesis.
- To elucidate the upstream regulation of CGRP in chronic migraine.
Main Methods:
- Generated chronic migraine models in mice using nitroglycerin (NTG) injections.
- Analyzed molecular changes in the spinal trigeminal nucleus caudalis (SP5C) and Neuro-2a cells via immunoblotting, qPCR, and immunofluorescence.
- Performed chromatin immunoprecipitation, dual-luciferase assays, coimmunoprecipitation, and synaptosomal CGRP analysis.
Main Results:
- NTG activated the CREB-KIF1A-CGRP pathway, inducing migraine-like hypersensitivity.
- CREB activation upregulated KIF1A and CGRP; inhibition reversed these effects.
- KIF1A physically associated with CGRP, and Kif1a knockdown alleviated hypersensitivity.
Conclusions:
- A CREB-KIF1A-CGRP positive feedback loop drives migraine-like hypersensitivity.
- CREB directly regulates KIF1A, promoting CGRP expression and signaling.
- Disrupting this axis attenuated migraine behaviors, indicating potential therapeutic targets.
Related Concept Videos
GPCRs Regulate Adenylyl Cylase Activity
7.3K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
7.3K
GPCR Desensitization
7.9K
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
7.9K
Pathophysiology of Vomiting
2.7K
Vomiting is a complex physiological response to expel harmful or irritating substances from the body. It's a defensive mechanism triggered by stimuli like poisons, microbial toxins, cytotoxic drugs, and mechanical abdominal distension. The process is centrally coordinated by the vomiting (or emetic) center located in the medulla of the brainstem. This area, rich in muscarinic M1, histamine H1, neurokinin 1 (NK1), and serotonin 5-HT3 receptors, coordinates the act of vomiting through...
2.7K
Analgesia and Pain Management
1.5K
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
1.5K
Calmodulin-dependent Signaling
6.0K
Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
6.0K

